Ortega J J, Javier G, Torán N
An Esp Pediatr. 1984 Sep 15;21(3):199-214.
The incidence of testicular infiltrates in 68 boys with acute lymphoblastic leukemia in first remission (1974-81), was prospectively investigated through careful clinical exams and routine bilateral biopsies at 2-3 years of remission. All boys were under 14 years of age and they were treated with protocols D.74 and pethema 7/78. Seven patients (10.3%) presented an isolated testicular relapse (ITR) during the chemotherapy period. In 13 out of the 43 testicular biopsies (31%) leukemic infiltrates were found and in other 2 findings were controversial. Three boys, two of them whose previous biopsy was negative, had an ITR, 6 to 18 months after stopping therapy. Finally, other 3 had simultaneous relapses in testes and bone-marrow: one during chemotherapy and two after suppression. In total, 23 patients (33.8%) in first remission had overt or occult ITR. Overall incidence of testes leukemia, is calculated to be 40% in all the group. Incidence of early and occult ITR was higher in boys with initial WBC counts over 20 X 10 9/l. Therapy in ITR generally consisted in local radiotherapy (20-25 Gy), a new induction treatment followed by 2 year maintenance treatment; in 3 patients with early ITR, orchidectomy was also performed and six were given a new preventive SNC treatment. Clinical course in the 7 patients with early ITR was unfavourable in 5 with subsequent hematological relapses and death; one had a long-term disease-free survival (78 + months) and the other was a recent case. 10 out of the 13 patients with occult infiltrates followed in remission and four were of treatment with a follow-up over 64 months. The 3 patients with late ITR were in second remission at 8-14 months after a new cessation of therapy. It may be concluded from this study that prognosis in ITR is related to the phase of presentation: It is unfavourable in cases of early ITR but in cases of occult infiltrates detected by routine biopsies and in late ITR the combined therapy is effective in most cases.
对68例首次缓解期的急性淋巴细胞白血病男孩(1974 - 1981年),通过仔细的临床检查和在缓解2 - 3年时进行的常规双侧活检,对睾丸浸润的发生率进行了前瞻性研究。所有男孩年龄均在14岁以下,采用D.74方案和pethema 7/78方案进行治疗。7例患者(10.3%)在化疗期间出现孤立性睾丸复发(ITR)。在43例睾丸活检中,13例(31%)发现白血病浸润,另外2例结果存在争议。3名男孩出现ITR,其中2名之前的活检为阴性,在停止治疗6至18个月后复发。最后,另外3例同时出现睾丸和骨髓复发:1例在化疗期间,2例在化疗抑制后。总共有23例首次缓解期患者(33.8%)出现明显或隐匿性ITR。整个研究组睾丸白血病的总体发生率计算为40%。初始白细胞计数超过20×10⁹/L的男孩早期和隐匿性ITR的发生率更高。ITR的治疗通常包括局部放疗(20 - 25 Gy),随后进行新的诱导治疗并维持治疗2年;3例早期ITR患者还进行了睾丸切除术,6例接受了新的预防性中枢神经系统治疗。7例早期ITR患者的临床病程中,5例预后不良,随后出现血液学复发并死亡;1例长期无病生存(78 + 个月),另1例为近期病例。13例隐匿性浸润患者中有10例在缓解期接受随访,4例接受治疗,随访时间超过64个月。3例晚期ITR患者在新的治疗停止8 - 14个月后处于第二次缓解期。从这项研究可以得出结论,ITR的预后与发病阶段有关:早期ITR预后不良,但对于通过常规活检检测到的隐匿性浸润和晚期ITR,联合治疗在大多数情况下是有效的。